FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic, Chicago, Illinois

Central Ohio Urology Group, Gahanna, Ohio

Carolina Urologic Research Center, Myrtle Beach, South Carolina